Insider · CIK 0001799731
Nazak Michael Adrian
Reports to the SEC for 2 companies · SAN JOSE, CA
Transactions
4
Companies
2
Filings
4
CIK
0001799731
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-02-15 | ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-05-12 | ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-02-18 | Aridis Pharmaceuticals, Inc.Stock OptionsM Exercise/Conversion | — |
| 2020-01-02 | Aridis Pharmaceuticals, Inc.Stock OptionsM Exercise/Conversion | — |
Recent filings
- 4Nazak Michael Adrian0000899243-23-005550SEC(opens sec.gov)
- 4Nazak Michael Adrian0000899243-22-018287SEC(opens sec.gov)
- 4Nazak Michael Adrian0001104659-21-026339SEC(opens sec.gov)
- 4Nazak Michael Adrian0001104659-20-003445SEC(opens sec.gov)
Companies
Address
C/O ARIDIS PHARMACEUTICALS, INC. 5941 OPTICAL COURT
SAN JOSE, CA, 95138